$7.00
Market Cap
$13.34M
Shares Outstanding
1.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Dec 9, 2021
Round Lot
100
Locale
US
Day Open
$7.04
Day High
$7.50
Day Low
$6.80
Volume
20.1K
VWAP
$7.11
Prev Close
$7.03
Transactions
--
Acc. Volume
--
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) closed the 2026-09-16 session at $7.00, down 0.43% versus the previous close (-0.03). The stock opened at $7.04 and traded between $6.80 and $7.50 during that session. Session trading volume was 20K shares. The volume-weighted average price (VWAP) is $7.11.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
NeuroSense Therapeutics Ltd. Ordinary Shares has a market capitalization of $13.3 million. NRSN is listed on the XNAS exchange. The company employs approximately 16 people. The recorded listing date is 2021-12-09.
On this page you can find market NRSN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.